ZHENG Xiaoyu , Vice President of GoBroad Healthcare Group, CEO of GoBroad Clinical Research Center, Dean of Beijing GoBroad Boren Hospital and Beijing GoBroad Hospital
14:00 - 14:25
主题报告
Keynote Speech
NK细胞免疫治疗
NK Cell-Based Immunotherapy
田志刚 中国工程院院士、欧洲科学院院士、中国科学技术大学教授
TIAN Zhigang , Academician of the Chinese Academy of Engineering, Academician of Academia Europaea, Professor of University of Science & Technology of China
14:25 - 14:50
主题报告
Keynote Speech
张宗久 清华大学医学院副主任、医院管理研究院常务副院长
ZHANG Zongjiu , Vice-Chancellor of Tsinghua Medicine and Executive Deputy Dean of Institute for Hospital Management, Tsinghua University
14:50 - 15:15
主题报告
Keynote Speech
增效细胞免疫抗肿瘤治疗的几个策略
Strategies to Enhance Cellular Immunotherapy in Cancer Treatment
韩为东 解放军总医院生物治疗科主任
HAN Weidong , Department of Biotherapeutics, Chinese People's Liberation Army General Hospital
15:15 - 15:45
主题报告
Keynote Speech
细胞治疗的发展:科学、技术与临床
The Development of Cell Therapy: Science, Technology and Clinic
张文杰 复星医药执行总裁、复星凯瑞董事长、复宏汉霖董事长
ZHANG Wenjie , Executive President of Fosun Pharma, Chairman of Fosun Kairos, Chairman of the board of Henlius.
15:45 - 16:35
第二阶段:基因研究创新技术
Session II: Innovative Technologies in Genetic Research
15:45 - 16:10
主题报告
Keynote Speech
高通量基因测序技术助力药物研发创新
NGS Technology Drives the Innovation in Drug Discovery
郑磊 因美纳全球高级副总裁兼大中华区总经理
Jenny ZHENG , SVP and GM of Greater China
16:10 - 16:35
主题报告
Keynote Speech
人工智能赋能的基因组结构变异检测算法
AI-empowered structural variation detection
叶凯 西安交通大学生物信息学研究所所长
YE Kai , Director of Bioinformatics Institute, Xi’an jiaotong University
16:35 - 17:30
主题讨论
Panel
探索细胞治疗和生物技术的未来发展
Exploration of the Future of Cell Therapy and Biotechnology
Moderator
张文杰 , 复星医药执行总裁、复星凯瑞董事长、复宏汉霖董事长
ZHANG Wenjie , Executive President of Fosun Pharma, Chairman of Fosun Kairos, Chairman of the board of Henlius.
Panelists
叶凯 , 西安交通大学生物信息学研究所所长
YE Kai , Director of Bioinformatics Institute, Xi’an jiaotong University
郑磊 , 因美纳全球高级副总裁兼大中华区总经理
Jenny ZHENG , SVP and GM of Greater China
王汉明 , 武汉滨会生物科技股份有限公司副总经理
WANG Hanming , Vice President of Binhui Biopharmaceutical Co., Ltd.